P/B
4
GSK
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
$100.1B
Market Cap • 10/30/2026
1999
(27 years)
Founded
1976
(50 years ago)
IPO
NYSE
Listing Exchange
United Kingdom
Country
Valuation
P/S
2,2
P/EBITDA
12,6
P/OCF
8,4
P/FCF
9,5
P/E
17,5
BVPS
12,3
EPS
2,8
Market Cap
Market Cap
100,1B
EV
127,7B
EV/Revenue
2,9
EV/EBITDA
16
EV/EBIT
16
Payout
Dividend Per Share
1,8
Dividend Yield
3,6%
Buyback Yield
1,2%
Total Yield
4,8%
Dividend Yield 5Y
3,7%
Payout
62,2%
Retained Earnings
16,5B
Profitability
Gross Margin
72,6%
EBITDA Margin
17,9%
EBIT Margin
17,9%
Net Margin
14,4%
D&A/EBITDA
0%
R&D/Revenue
28,3%
Capex/Revenue
3%
Capex/D&A
0%
Capex/OCF
11,4%
SBC/OCF
—
% PPE
14,1%
% Goodwill
11,5%
ROE
28,1%
ROIC
10,5%
Growth
CAGR Revenue 5Y
4,4%
CAGR Op. Income 5Y
3,4%
CAGR Net Income 5Y
3,5%
CAGR EPS 5Y
-0,6%
CAGR OCF 5Y
1,1%
Leverage
N.D./EBITDA
3,4
Debt/Equity
0%
Current Ratio
0,9
Quick Ratio
0,6
Interest Coverage
793%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!